151 related articles for article (PubMed ID: 23864796)
1. Vaccines against Coccidioides.
Yoon HJ; Clemons KV
Korean J Intern Med; 2013 Jul; 28(4):403-7. PubMed ID: 23864796
[TBL] [Abstract][Full Text] [Related]
2. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
3. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
Walch HA; Kalvoda A
Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
[No Abstract] [Full Text] [Related]
4. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
Pappagianis D
Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
[TBL] [Abstract][Full Text] [Related]
5. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
6. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
Fierer J; Waters C; Walls L
J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity in coccidioidomycosis.
Cox RA; Magee DM
Res Immunol; 1998; 149(4-5):417-28; discussion 506-7. PubMed ID: 9720959
[No Abstract] [Full Text] [Related]
9. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
10. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
[No Abstract] [Full Text] [Related]
11. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
12. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
Kirkland TN; Fierer J
Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
[TBL] [Abstract][Full Text] [Related]
13. Development of vaccines for coccidioidomycosis.
Levine HB; Pappagianis D; Cobb JM
Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
[No Abstract] [Full Text] [Related]
14. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
15. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
16. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
17. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
18. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
[No Abstract] [Full Text] [Related]
19. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
